Dr. Scott R. McGlynn, MD

Dr. McGlynn practices at Southampton Hospital in Southampton, New York.

Dr. McGlynn's NPI, 1922096106, was assigned on October 11, 2005. Dr. McGlynn graduated from Drexel University College Of Medicine in 1997. Dr. McGlynn's Georgia license number on file is 060679.

Dr. McGlynn's primary practice is Southampton Hospital, at 240 Meeting House Ln, Southampton, NY 11968 in Suffolk County. The practice phone is (631) 726-8200.

Dr. McGlynn's primary practice is Southampton Hospital in Southampton, New York. Dr. McGlynn is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Internists. Dmand AI also links Dr. McGlynn to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGlynn practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. McGlynn's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. McGlynn is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. McGlynn's licenses on file in 4 states: Georgia, New York, Colorado and District of Columbia.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and endocarditis among the conditions Dr. McGlynn treats.

CMS data shows 2,038 Medicare services from Dr. McGlynn across 17 procedure codes in 2024, for 821 Medicare patients. Medicare paid $155,465 for them.

CMS counts 821 Medicare patients who saw Dr. McGlynn in 2024. The largest group is 75 to 84, with 326 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGlynn's median patient age at 73, with 38% women.

In 2024, Dr. McGlynn wrote 516 Medicare Part D claims for 130 patients. 82% of them were for generic drugs. CMS names the drug for 393 of them, across 14 drugs with 11 or more claims each, at $95,857 in total drug cost. In 2023, CMS named 474 claims across 15 drugs.

Dr. McGlynn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 212 general payments to Dr. McGlynn from 33 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Amgen Inc. paid the most, $497.

Dmand AI lists 3 awards for Dr. McGlynn, most recently NCQA HSRP in 2013.

Dr. McGlynn graduated from Drexel University College Of Medicine in 1997. Dr. McGlynn is a member of ACC.

Dr. McGlynn is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.